For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...

About 1 in 10 adults aged 70 or older may be eligible for anti-amyloid therapy, finds the first population-based study to use ...

Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

Scientists at Northwestern University have identified a previously hidden toxic protein that may trigger Alzheimer’s disease ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

Thankfully, Sen. Tim Kaine can play an important role in accelerating access to blood biomarker tests and earlier detection ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...